Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

SELL
$27.36 - $35.98 $409,551 - $538,584
-14,969 Closed
0 $0
Q2 2021

Sep 17, 2021

BUY
$28.9 - $36.87 $432,604 - $551,907
14,969 New
14,969 $527,000
Q3 2020

Dec 11, 2020

SELL
$23.19 - $41.61 $191,456 - $343,532
-8,256 Closed
0 $0
Q2 2020

Aug 07, 2020

BUY
$14.82 - $29.92 $122,353 - $247,019
8,256 New
8,256 $219,000

Others Institutions Holding ALBO

About ALBIREO PHARMA, INC.


  • Ticker ALBO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 19,612,500
  • Description
  • Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...
More about ALBO
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.